|
Thermo Fisher
snp cyp2c19 c 30634130 30  Snp Cyp2c19 C 30634130 30, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/snp+cyp2c19+c+30634130+30/SNP+CYP2C19%2C+C__30634130_30/pmc08471120-5-10--1 Average 93 stars, based on 1 article reviews
snp cyp2c19 c 30634130 30 - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Personalized Medicine
Article Title: Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
doi: 10.3390/jpm11090851
Figure Lengend Snippet: NeuroPGx panel (based on OpenArray™ technology).
Article Snippet: , , *8 , 12711T > C , rs41291556 ,
Techniques: Variant Assay
Journal: Journal of Personalized Medicine
Article Title: Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
doi: 10.3390/jpm11090851
Figure Lengend Snippet: Selected drugs and CYP genes associated.
Article Snippet: , , *8 , 12711T > C , rs41291556 ,
Techniques:
5 ]. Abbr.: SSA = Sub-Saharan African; AA/AC = African American/Afro-Carribbean; Eur = European; NE = Near Eastern; EA = East Asian; CSA = Central/South Asian; Ame = American; Lat = Latino; Oce = Oceanian; AF = allele frequency." width="100%" height="100%">
Journal: Journal of Personalized Medicine
Article Title: Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
doi: 10.3390/jpm11090851
Figure Lengend Snippet: Selected SNPs. Frequency of detectable alleles have been calculated according to population data [
Article Snippet: , , *8 , 12711T > C , rs41291556 ,
Techniques:
Journal: Journal of Personalized Medicine
Article Title: Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
doi: 10.3390/jpm11090851
Figure Lengend Snippet: Comparison between guidelines (CPIC and DPWG) and drug labels (FDA and EMA/AIFA) for pharmacogenetic data. Abbr.: FDA = Food and Drug Administration; EMA = European Medicines Agency; AIFA = Italian Medicines Agency; noRec = no recommendation reported in the guideline; N = no information about CYP phenotypes; Y = the label reports information about CYP phenotypes, with or without suggestion to investigate CYP genotype; NA: not approved.
Article Snippet: , , *8 , 12711T > C , rs41291556 ,
Techniques: Comparison